Advertisement

Klinische Wochenschrift

, Volume 67, Issue 20, pp 1061–1065 | Cite as

Unusually rapid development of a HBsAG-positive liver cirrhosis after liver transplantation

  • H. -U. Lautz
  • R. Müller
  • C. Wittekind
  • S. Mauz
  • H. Barg-Hock
  • B. Ringe
  • R. Pichlmayr
  • F. W. Schmidt
Case Report

Summary

We report the case of a 44-year-old man who was transplanted in 1986 for hepatocellular carcinoma in a HBsAG-positive liver cirrhosis. The patient had no severe complications postoperatively. He received passive immunization for the prevention of hepatitis B reinfection during the first 6 months after liver grafting. Twelve months after the transplantation the new liver was reinfected with hepatitis B virus. Without any clinical or laboratory signs of severe hepatitis, the patient developed a histologically proven complete liver cirrhosis within 8 months after reinfection of the graft. The reasons for this might have been, first, a deleterious course of the infection under immunosuppressive therapy, and, second, the additional influence of a postoperatively acquired CMV infection or the combined toxic influence of cyclosporin A and its metabolites on the acute inflammation in the liver.

Key words

Liver cirrhosis Liver transplantation Hepatitis B 

Abbreviations

ALT

Alanine aminotransferase (EC No 2.6.1.2)

AST

Aspartate aminotransferase (EC No 2.6.1.1)

CMV

Cytomegalo virus

EBV

Ebstein-Barr virus

ELISA

Enzyme linked immunosorbentassay

HBV

Hepatitis B virus

HLA

Human leukocyte antigen

HSV

Herpes simplex virus

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bismuth H, Ericzon BG, Rolles K, Castaing D, Otte JB, Ringe B, Sloof M (1987) Hepatic transplantation in Europe. Lancet I:674–676Google Scholar
  2. 2.
    Calne RY, Williams R, Rolles K (1986) Liver transplantation in the adult. World J Surg 10:422–431Google Scholar
  3. 3.
    Demetris AJ, Sheahan DG, Burnham J, Spero J, Iwatsuki S, van Thiel DH, Starzl TE (1986) Recurrent hepatitis B in liver allograft recipients. Am J Pathol 125:161–172Google Scholar
  4. 4.
    Dienstag JL (1988) Renal transplantation and hepatitis B. Gastroenterology 94:235–238Google Scholar
  5. 5.
    Feldmann H, Wittekind CH, Kemnitz J, Lautz HU, Müller R, Ringe B (1988) Rezidivhäufigkeit und Entwicklung von Hepatitis-B-Infektionen bei wegen einer Hepatitis-B transplantierten Patienten. Verh Dtsch Ges Path 72:572Google Scholar
  6. 6.
    Harnett JD, Zeldis JB, Parfrey PS, Kennedy M, Sircar R, Steinmann TI, Guttermann RD (1987) Hepatitis B disease in dialysis and transplant patients. Transplantation 44:369–376Google Scholar
  7. 7.
    Hoofnagle JH, Seeff LB (1984) Natural history of chronic type B hepatitis. Prog in Liver Dis 7:469–479Google Scholar
  8. 8.
    Klintmalm GBG, Iwatsuki S, Starzl TE (1981) Hepatotoxicity in 66 renal allograft recipients. Transplantation 32:488–489Google Scholar
  9. 9.
    Koff RS, Galambos J (1982) Viral hepatitis. In: Schiff L, Schiff ER (eds) Diseases of the liver, 5th edn. Lippincott, Philadelphia, pp 461–610Google Scholar
  10. 10.
    Lam KC, Lai CL, Trepo C, Wu PC (1981) Deleterious offect of prednisolone in HBsAG positive chronic active hepatitis. N Engl J Med 304:380–386Google Scholar
  11. 11.
    Marsh JW, Makowka L, Todo S, Gordon RD, Esquivel CO, Tzakis A, Iwatsuki S, Starzl TE (1987) Liver transplantation today. Postgrad Med 81:13–23Google Scholar
  12. 12.
    Müller R, Lauchart W, Farle M, Klein H, Niehoff G, Pichlmayr R (1988) Simultaneous passive-active immunization to prevent HBV-reinfection in HBsAG positive liver transplant recipients. In: Zuckerman AJ (ed) Viral hepatitis and liver disease. Alan R. Liss, New York, p 810Google Scholar
  13. 13.
    Pichlmayr R, Müller R, Schmidt FW, Brunner G, Burdelski M (1987) Die Lebertransplantation: Aktueller Stand und Indikation. Internist 28:1–7Google Scholar
  14. 14.
    Steinhoff G, Wonigeit K, Pichlmayr R (1988) Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 45:394–401Google Scholar
  15. 15.
    Stone BG, Kolani M, Sanghvi A, Warty V, Plockli K, Bedetti CD, van Thiel DH (1987) Cyclosporin A induced cholestasis. Gastroenterology 93:344–351Google Scholar
  16. 16.
    Tong MJ, Liu S, Co CL (1987) Persistence of serum hepatitis B virus DNA in hepatitis B surface antigen positive patients with chronic persistent hepatitis treated with prednisolone. Gastroenterology 92:862–866Google Scholar
  17. 17.
    Vandelli C, Zannini A, Piraggi V, Melegari M, Battilani R, Ventura E (1987) What is the effect of a cytomegalovirus infection when superimposed on HBsAG positive chronic hepatitis? J Hepatol 4:342–348Google Scholar
  18. 18.
    Williams R, Alexander GJM (1986) Natural history of chronic hepatitis B related liver disease and its relationship to serum markers of viral replication. J Hepatol [Suppl 2] 3:S3-S8Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • H. -U. Lautz
    • 1
  • R. Müller
    • 1
  • C. Wittekind
    • 2
  • S. Mauz
    • 3
  • H. Barg-Hock
    • 3
  • B. Ringe
    • 3
  • R. Pichlmayr
    • 3
  • F. W. Schmidt
    • 1
  1. 1.Abteilung Gastroenterologie u. Hepatologie im Zentrum Innere Medizin und DermatologieGermany
  2. 2.Pathologisches InstitutGermany
  3. 3.Klinik für Abdominal- und Transplantationschirurgie Medizinische Hochschule HannoverGermany

Personalised recommendations